DNA Methylation as a Biomarker for Cardiovascular Disease Risk

被引:289
|
作者
Kim, Myungjin [1 ,2 ]
Long, Tiffany I. [1 ,2 ]
Arakawa, Kazuko [1 ,2 ]
Wang, Renwei [3 ]
Yu, Mimi C. [3 ]
Laird, Peter W. [1 ,2 ]
机构
[1] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA
[2] Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90033 USA
[3] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
来源
PLOS ONE | 2010年 / 5卷 / 03期
关键词
S-ADENOSYLHOMOCYSTEINE; PLASMA HOMOCYSTEINE; EXPRESSION; HYPOMETHYLATION; ATHEROSCLEROSIS; PATTERNS; MICE;
D O I
10.1371/journal.pone.0009692
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Elevated serum homocysteine is associated with an increased risk of cardiovascular disease (CVD). This may reflect a reduced systemic remethylation capacity, which would be expected to cause decreased genomic DNA methylation in peripheral blood leukocytes (PBL). Methodology/Principal Findings: We examined the association between prevalence of CVD (myocardial infarction, stroke) and its predisposing conditions (hypertension, diabetes) and PBL global genomic DNA methylation as represented by ALU and Satellite 2 (AS) repetitive element DNA methylation in 286 participants of the Singapore Chinese Health Study, a population-based prospective investigation of 63,257 men and women aged 45-74 years recruited during 1993-1998. Men exhibited significantly higher global DNA methylation [geometric mean (95% confidence interval (CI)): 159 (143, 178)] than women [133 (121, 147)] (P= 0.01). Global DNA methylation was significantly elevated in men with a history of CVD or its predisposing conditions at baseline (P= 0.03) but not in women (P= 0.53). Fifty-two subjects (22 men, 30 women) who were negative for these CVD/predisposing conditions at baseline acquired one or more of these conditions by the time of their follow-up I interviews, which took place on average about 5.8 years post-enrollment. Global DNA methylation levels of the 22 incident cases in men were intermediate (AS, 177) relative to the 56 male subjects who remained free of CVD/predisposing conditions at follow-up (lowest AS, 132) and the 51 male subjects with a diagnosis of CVD or predisposing conditions reported at baseline (highest AS 184) (P for trend = 0.0008) No such association was observed in women (P = 0.91). Baseline body mass index was positively associated with AS in both men and women (P= 0.007). Conclusions/Significance: Our findings indicate that elevated, not decreased, PBL DNA methylation is positively associated with prevalence of CVD/predisposing conditions and obesity in Singapore Chinese.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Is Any Cardiovascular Disease-Specific DNA Methylation Biomarker Within Reach?
    Carmen de la Rocha
    Silvio Zaina
    Gertrud Lund
    Current Atherosclerosis Reports, 2020, 22
  • [2] Is Any Cardiovascular Disease-Specific DNA Methylation Biomarker Within Reach?
    de la Rocha, Carmen
    Zaina, Silvio
    Lund, Gertrud
    CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (10)
  • [3] Neighborhood Environment and DNA Methylation: Implications for Cardiovascular Disease Risk
    Carmen Giurgescu
    Alexandra L. Nowak
    Shannon Gillespie
    Timiya S. Nolan
    Cindy M. Anderson
    Jodi L. Ford
    Daryl B. Hood
    Karen Patricia Williams
    Journal of Urban Health, 2019, 96 : 23 - 34
  • [4] Neighborhood Environment and DNA Methylation: Implications for Cardiovascular Disease Risk
    Giurgescu, Carmen
    Nowak, Alexandra L.
    Gillespie, Shannon
    Nolan, Timiya S.
    Anderson, Cindy M.
    Ford, Jodi L.
    Hood, Daryl B.
    Williams, Karen Patricia
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2019, 96 (Suppl 1): : 23 - 34
  • [5] A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events
    Andrea Cappozzo
    Cathal McCrory
    Oliver Robinson
    Anna Freni Sterrantino
    Carlotta Sacerdote
    Vittorio Krogh
    Salvatore Panico
    Rosario Tumino
    Licia Iacoviello
    Fulvio Ricceri
    Sabina Sieri
    Paolo Chiodini
    Gareth J. McKay
    Amy Jayne McKnight
    Frank Kee
    Ian S. Young
    Bernadette McGuinness
    Eileen M. Crimmins
    Thalida Em Arpawong
    Rose Anne Kenny
    Aisling O’Halloran
    Silvia Polidoro
    Giuliana Solinas
    Paolo Vineis
    Francesca Ieva
    Giovanni Fiorito
    Clinical Epigenetics, 2022, 14
  • [6] A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events
    Cappozzo, Andrea
    McCrory, Cathal
    Robinson, Oliver
    Sterrantino, Anna Freni
    Sacerdote, Carlotta
    Krogh, Vittorio
    Panico, Salvatore
    Tumino, Rosario
    Iacoviello, Licia
    Ricceri, Fulvio
    Sieri, Sabina
    Chiodini, Paolo
    McKay, Gareth J.
    McKnight, Amy Jayne
    Kee, Frank
    Young, Ian S.
    McGuinness, Bernadette
    Crimmins, Eileen M.
    Arpawong, Thalida Em
    Kenny, Rose Anne
    O'Halloran, Aisling
    Polidoro, Silvia
    Solinas, Giuliana
    Vineis, Paolo
    Ieva, Francesca
    Fiorito, Giovanni
    CLINICAL EPIGENETICS, 2022, 14 (01)
  • [7] DNA methylation as a biomarker for breast cancer risk
    Zapparoli, G.
    Sullivan, R.
    Kim, S.
    Cangiarella, J.
    Skinner, K. A.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 75 - 75
  • [8] DNA methylation and incident cardiovascular disease
    Westerman, Kenneth E.
    Ordovas, Jose M.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2020, 23 (04): : 236 - 240
  • [9] Associations between DNA Methylation of Four Genes and Risk of Cardiovascular Disease in the Cardiovascular Health Study
    Fitzpatrick, Annette I.
    Belshaw, Nigel J.
    Jenny, Nancy S.
    Leung, Wing C.
    Shrestha, Archana
    Tapp, Henri S.
    CIRCULATION, 2013, 127 (12)
  • [10] Impact of inflammation on epigenetic DNA methylation -: a novel risk factor for cardiovascular disease?
    Stenvinkel, P.
    Karimi, M.
    Johansson, S.
    Axelsson, J.
    Suliman, M.
    Lindholm, B.
    Heimburger, O.
    Barany, P.
    Alvestrand, A.
    Nordfors, L.
    Qureshi, A. R.
    Ekstrom, T. J.
    Schalling, M.
    JOURNAL OF INTERNAL MEDICINE, 2007, 261 (05) : 488 - 499